QUANTITATIVE STUDY TWO COMPONENT MIXTURE CONTAINING PARACETAMOL AND IBUPROFEN IN SOLID PHARMACEUTICAL DOSAGE FORMS BY RATIO ULTRAVIOLET SPECTROSCOPY
Main Article Content
Abstract
Using ratio ultraviolet spectroscopy to determine the concentration of substances in a two component mixture containing paracetamol (PA) and ibuprofen (IBU) without chemical treatment, the solvent used in the analysis is methanol. The relative ultraviolet spectroscopy method is based on the difference between the peak amplitude of the proportional spectrum at two wavelengths to build regression equations and analytical parameters. The two wavelengths selected in the ratio spectrum for PA, IBU are 247 and 272 nm, 217 and 245 nm, respectively. The concentration range considered linear for the two substances is 4- 32 µg/ml; The LOD and LOQ of PA, IBU were 0.50, 1.13 µg/ml and 1.51, 3.39 µg/ml, respectively. The ratio ultraviolet spectroscopy method has successfully determined the concentrations of the two substances in a mixture of laboratory and three commercial drugs.
Article Details
Keywords
paracetamol, ibuprofen, ratio ultraviolet spectroscopy, quantitative, mixture
References
2. G. Gazal and I. C. Mackie, “A comparison of paracetamol, ibuprofen or their combination for pain relief following extractions in children under general anaesthesia: A randomized controlled trial,” Int. J. Paediatr. Dent., vol. 17, no. 3, pp. 169–177, 2007, doi: 10.1111/j.1365-263X.2006.00806.x.
3. M. Simpson, M. Drum, J. Nusstein, A. Reader, and M. Beck, “Effect of combination of preoperative ibuprofen/acetaminophen on the success of the inferior alveolar nerve block in patients with symptomatic irreversible pulpitis,” J. Endod., vol. 37, no. 5, pp. 593–597, 2011, doi: 10.1016/j.joen.2011.02.015.
4. W. J. Blot et al., “Outcome of upper gastro-intestinal bleeding and use of ibuprofen versus paracetamol.,” Pharm. World Sci., vol. 26, no. 6, pp. 319–323, 2004, doi: 10.1007/s11096-004-9008-5.
5. H. F. Miranda, M. M. Puig, J. C. Prieto, and G. Pinardi, “Synergism between paracetamol and nonsteroidal anti-inflammatory drugs in experimental acute pain,” Pain, vol. 121, no. 1–2, pp. 22–28, 2006, doi: 10.1016/j.pain.2005.11.012.
6. D. R. Mehlisch, S. Aspley, S. E. Daniels, K. A. Southerden, and K. S. Christensen, “A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: A multicenter, two-stage, randomized, double-blind, parallel-group, placebo-control,” Clinical Therapeutics, vol. 32, no. 6. pp. 1033–1049, 2010, doi: 10.1016/j.clinthera.2010.06.002.
7. E. K. Darkwah, C. K. Acquah, P. S. Lambon, D. K. Ameko, O. Akanji, and J. S. K. Ayim, “Simultaneous Quantification of Acetaminophen, Caffeine, and Ibuprofen in Fixed Dose Combination Drug Using HPLC with UV Detection,” J. Adv. Med. Pharm. Sci., pp. 1–19, 2019.
8. M. R. Khoshayand, H. Abdollahi, M. Shariatpanahi, A. Saadatfard, and A. Mohammadi, “Simultaneous spectrophotometric determination of paracetamol, ibuprofen and caffeine in pharmaceuticals by chemometric methods,” Spectrochim. Acta - Part A Mol. Biomol. Spectrosc., vol. 70, no. 3, pp. 491–499, 2008.
9. Nguyễn Đức Thiện và Nguyễn Thị Mỹ Linh, “Nghiên cứu định lượng atorvastatin calcium và ezetimibe trong chế phẩm viên nén bằng quang phổ tử ngoại tỷ đối,” Y Dược học, pp. 26–33, 2022.
10. A. Teasdale, D. Elder, and R. W. Nims, “Q2 ( R1 ) Validation of Analytical Procedures,” vol. 2, pp. 127–166, 2018.